AMTG-DA1

• Description:

  AMTG-DA1 is a Gastrin-releasing peptide receptor (GRPR) ligand. AMTG-DA1 can be used in the study of cancer[1].

• UNSPSC:

  12352211

• Target:

  Bombesin Receptor

• Related Pathways:

  GPCR/G Protein

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Smiles:

  O=C(N[C@H](C(O)=O)CCCCNC(CCCC1=CC=C(I)C=C1)=O)CCC(N2CCN(CC(O)=O)CCN(C(C(O)=O)CCC(NC(CC3)CCN3CC(N[C@@H](C(N[C@H](C(N[C@](C)(C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H]([C@H](CC(N[C@@H](CC(C)C)C(N)=O)=O)O)CC(C)C)=O)CC4=CNC=N4)=O)=O)C(C)C)=O)C)=O)CC5=CNC6=C5C=CC=C6)=O)CCC(N)=O)=O)CC7=CC=CC=C7)=O)=O)CCN(CC(O)=O)CC2)C(O)=O

• Molecular Formula:

  C101H149IN22O25

• Molecular Weight:

  2198.30

• References & Citations:

  [1]Tsuchihashi S, et al. Development of Novel Gastrin-Releasing Peptide Receptor-Targeted Radioligand with Albumin Binder to Improve Accumulation in Tumor. ACS Med Chem Lett. 2025 Apr 25;16 (5) :797-803.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported